Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
Vaccine Science & Safety - NFID
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
COVID-19 vaccine tracker and landscape
Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy | Nature Communications
KFF COVID-19 Vaccine Monitor: December 2020 | KFF
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Vaccine Safety - Vaccinate Your Family
South Australian Omicron COVID-19 booster vaccine starting human trials | Newsroom | University of Adelaide
Local Research Study Confirms COVID-19 Vaccine Safety – Med Center Health
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety | Nature Reviews Clinical Oncology
Vaccine Safety - Vaccinate Your Family
CIRN Canadian Immunization Research Network
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines: Molecular Therapy
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal | University of Oxford
Ensuring vaccine safety | Science
Texas Children's Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India | Texas Children's Hospital
Vaccine misinformation poised to spike as Covid shots for kids roll out
10 Reasons to Get Vaccinated - NFID
COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors - Mohammad S Razai, Pippa Oakeshott, Aneez Esmail, Charles Shey Wiysonge, Kasisomayajula Viswanath, Melinda C Mills, 2021